Susla GM - Search Results

1

Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature.

Sevransky JE, Nour S, Susla GM, Needham DM, Hollenberg S, Pronovost P. Sevransky JE, et al. Among authors: susla gm. Crit Care. 2007;11(3):R67. doi: 10.1186/cc5948. Crit Care. 2007. PMID: 17584921 Free PMC article. Review.

2

Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock.

Kalil AC, Sevransky JE, Myers DE, Esposito C, Vandivier RW, Eichacker P, Susla GM, Solomon SB, Csako G, Costello R, Sittler KJ, Banks S, Natanson C, Danner RL. Kalil AC, et al. Among authors: susla gm. Crit Care Med. 2006 Nov;34(11):2719-28. doi: 10.1097/01.CCM.0000242757.26245.03. Crit Care Med. 2006. PMID: 16971848

3

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.

Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S. Hollenberg SM, et al. Among authors: susla gm. Crit Care Med. 2004 Sep;32(9):1928-48. doi: 10.1097/01.ccm.0000139761.05492.d6. Crit Care Med. 2004. PMID: 15343024 Review.

4

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.

Shorr AF, Susla GM, Kollef MH. Shorr AF, et al. Among authors: susla gm. Crit Care Med. 2004 Jan;32(1):137-43. doi: 10.1097/01.CCM.0000104110.74657.25. Crit Care Med. 2004. PMID: 14707572

5

Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.

Quezado ZM, Hoffman WD, Banks SM, Danner RL, Eichacker PQ, Susla GM, Natanson C. Quezado ZM, et al. Among authors: susla gm. J Pharmacol Exp Ther. 1999 Jan;288(1):107-13. J Pharmacol Exp Ther. 1999. PMID: 9862760

6

Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes.

Shorr AF, Susla GM, O'Grady NP. Shorr AF, et al. Among authors: susla gm. Chest. 2004 Jan;125(1):260-71. doi: 10.1378/chest.125.1.260. Chest. 2004. PMID: 14718449 Review.

7

Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.

Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PD; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians. Murray MJ, et al. Crit Care Med. 2002 Jan;30(1):142-56. doi: 10.1097/00003246-200201000-00021. Crit Care Med. 2002. PMID: 11902255 No abstract available.

8

Weight-based heparin dosing: maybe it's just a matter of time.

Susla GM. Susla GM. Crit Care Med. 1997 Sep;25(9):1451-2. doi: 10.1097/00003246-199709000-00005. Crit Care Med. 1997. PMID: 9295812 No abstract available.

9

Antiendotoxin monoclonal antibodies. What future now?

Susla GM, Dew RB. Susla GM, et al. Drug Saf. 1994 Oct;11(4):215-22. doi: 10.2165/00002018-199411040-00001. Drug Saf. 1994. PMID: 7848542 Review. No abstract available.

10

Antibiotic Dosing in Critically Ill Patients Undergoing Renal Replacement Therapy.

Susla GM. Susla GM. AACN Adv Crit Care. 2015 Jul-Sep;26(3):244-51. doi: 10.1097/NCI.0000000000000098. AACN Adv Crit Care. 2015. PMID: 26200733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters